JP Morgan Chase’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Buy
67,326
+10,491
+18% +$146K ﹤0.01% 4429
2025
Q4
$504K Buy
56,835
+22,919
+68% +$197K ﹤0.01% 5047
2025
Q3
$285K Sell
33,916
-32,759
-49% -$222K ﹤0.01% 5323
2025
Q2
$341K Buy
66,675
+35,439
+113% +$87.6K ﹤0.01% 4969
2025
Q1
$42.8K Sell
31,236
-77
-0.2% -$189 ﹤0.01% 5936
2024
Q4
$96.8K Sell
31,313
-21,527
-41% -$100K ﹤0.01% 5770
2024
Q3
$407K Buy
52,840
+1,281
+2% +$12.2K ﹤0.01% 5040
2024
Q2
$442K Sell
51,559
-71,138
-58% -$550K ﹤0.01% 4754
2024
Q1
$974K Buy
122,697
+72,894
+146% +$781K ﹤0.01% 4366
2023
Q4
$493K Buy
49,803
+2,551
+5% +$22.1K ﹤0.01% 4806
2023
Q3
$532K Buy
47,252
+7,624
+19% +$46.5K ﹤0.01% 4440
2023
Q2
$132K Sell
39,628
-21,341
-35% -$76.8K ﹤0.01% 5329
2023
Q1
$241K Buy
60,969
+10,980
+22% +$63.7K ﹤0.01% 4953
2022
Q4
$363K Buy
49,989
+8,134
+19% +$57.2K ﹤0.01% 4717
2022
Q3
$151K Sell
41,855
-7,472
-15% -$31.9K ﹤0.01% 5081
2022
Q2
$224K Buy
49,327
+23,090
+88% +$140K ﹤0.01% 5021
2022
Q1
$199K Sell
26,237
-6,298
-19% -$54.6K ﹤0.01% 5198
2021
Q4
$357K Buy
32,535
+30,723
+1,696% +$369K ﹤0.01% 5029
2021
Q3
$23K Buy
+1,812
New +$21.7K ﹤0.01% 6020
2020
Q4
Sell
-100,000
Closed -$1.02M 5930
2020
Q3
$1.02M Buy
+100,000
New +$1.02M ﹤0.01% 3632

Other funds holding TNGX